SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
, April 28, 2025 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion of its ongoing collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to accelerate the deployment of MSK-ACCESS® powered with SOPHiA DDM™ globally. Building on the initial collaboration announced in October 2024, this new phase will extend the test's reach to a total of 30 clinical institutions worldwide in 2025.
Developed in collaboration with Memorial Sloan Kettering Cancer Center, MSK-ACCESS® powered with SOPHiA DDM™ is an innovative liquid biopsy testing application designed to detect actionable genomic alterations from a single blood draw using proprietary, state-of-the-art algorithms which analyze circulating tumor DNA (ctDNA). The application supports real-time cancer monitoring and treatment selection when traditional tissue biopsies are not feasible due to cost, turnaround time, insufficient tissue, or the invasiveness of the procedure.
The expanded rollout will continue to contribute to AstraZeneca's global real-world evidence initiatives and help further validate the clinical impact of decentralized liquid biopsy testing across diverse healthcare systems. By increasing the availability of MSK-ACCESS® powered with SOPHiA DDM™, SOPHiA GENETICS and AstraZeneca aim to understand further how liquid biopsy testing can complement solid tissue testing and, in some cases, provide greater benefit for labs and patients.
The announcement coincides with SOPHiA GENETICS's presentation at AACR, in which the company presented data demonstrating the robust transferability of the decentralized MSK-ACCESS® powered with SOPHiA DDM TM solution. Historically, site-to-site discordance has been a major barrier to the widespread adoption of liquid biopsy testing. SOPHiA GENETICS presented real-world data highlighting the consistent accuracy and precision of MSK-ACCESS® powered with SOPHiA DDM TM across various laboratory settings. Interim results from the multi-center study demonstrated the high analytical performance of the decentralized test in line with the original single-site test at Memorial Sloan Kettering Cancer Center in New York.
"Our collaboration with AstraZeneca represents a significant step toward scaling next-generation oncology diagnostics globally," said Ross Muken, President, SOPHiA GENETICS. "This expanded deployment reflects the growing momentum behind liquid biopsy and our shared ambition to make these technologies more accessible and impactful worldwide."
Visit SOPHiA GENETICS at the American Association for Cancer Research's Annual Meeting in Chicago, Illinois from April 25 th –30 th to learn more about how SOPHiA GENETICS is collaborating with AstraZeneca to transform patient care with data-driven medicine.
For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact [email protected] to obtain the appropriate product information for your country of residence.
SOPHiA GENETICS Forward-Looking Statements:
This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Regency Centers Invites You to Join Its Second Quarter 2025 Earnings Conference Call
JACKSONVILLE, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation ('Regency Centers' or the 'Company') (NASDAQ: REG) will announce its second quarter 2025 earnings results on Tuesday, July 29, 2025, after the market closes. The Company's earnings release and supplemental information package will be posted on the Investor Relations section of the Company's website – The Company will host an earnings conference call on Wednesday, July 30, 2025, at 11:00 a.m. ET. Second Quarter 2025 Earnings Conference Call Date: Wednesday, July 30, 2025 Time: 11:00 a.m. ET Dial#: 877-407-0789 or 201-689-8562 Webcast: 2nd Quarter 2025 Webcast Link Replay About Regency Centers Corporation (NASDAQ: REG) Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member. For more information, please visit
Cision Canada
an hour ago
- Cision Canada
EnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology Assets
This acquisition significantly strengthens EnChannel's intellectual property portfolio by integrating key innovations in second- and third-generation non-contact mapping (NCM) technologies. These technologies form the foundation for full-chamber atrial fibrillation (AF) mapping – a critical capability for understanding AF mechanisms and delivering effective, personalized treatment. "This strategic acquisition accelerates our mission to visualize and treat AF with unprecedented efficiency and precision," said Jun Feng, CEO of EnChannel Medical. "By building on prior advancements and leveraging our proprietary technologies, we are shaping the future of persistent AF diagnosis and treatment." Contact and Non-Contact Mapping in Perspective Conventional contact mapping systems sequentially collect electrical signals by making physical contact with many small regions of cardiac tissue, generating regional maps of electrical activity over numerous beats that are gradually assembled into a composite view across the chamber surface. While effective for regular rhythms, it is time-consuming, and it cannot capture the full dynamics of irregular activation patterns, such as in AF, often averaging out critical details and reducing mapping accuracy and specificity. In contrast, non-contact mapping (NCM) reconstructs full-chamber electrical activity from cardiac signals sensed by numerous electrodes distributed within the atrial chamber cavity. NCM delivers a comprehensive, single-beat depiction of activation over the entire atrial chamber at every instance of time. This approach significantly improves mapping efficiency and preserves the dynamic patterns of both regular and complex, irregular rhythms, including AF. Acutus' AcQMap™ technology is a second-generation NCM platform that advanced beyond the first-generation voltage-to-voltage mapping (pioneered by Endocardial Solutions – now part of Abbott), and delivered improved spatial resolution and accuracy, using voltage-to-charge-density mapping. Advancing the Frontier of Non-Contact Mapping EnChannel's propriety Action Potential Mapping offers a third-generation breakthrough in NCM technology, with accurate reconstruction of both depolarization and repolarization dynamics. This fulfills a biophysical unmet need that remains in conventional mapping, which cannot address repolarization. Action Potential Mapping therefore approaches the real nature of cardiac conduction and enables comprehensive understanding of the mechanisms that initiate and maintain AF – laying the groundwork for precise, individualized treatment of persistent AF. "Many of us at EnChannel had essential roles in developing all three generations of non-contact mapping," said Graydon Beatty, CSO of EnChannel Medical. "Each generation informed and enabled the next one; from reproduction of the cardiac signal in the first; to resolving the physical electric source of the signal in the second; and now culminating in reconstruction of the physiologic action potential in the third, revealing the actual nature of cardiac conduction dynamics. This acquisition unites our history of requisite methods and resources across the generations, and advances a hybrid workflow of all modes of navigation, mapping, and visualization. We are poised and resolved to establish an electrophysiology ecosystem that uncovers the mechanisms of AF, optimizes patient-specific treatment, and improves clinical outcomes in persistent AF." About EnChannel Medical Founded in 2020 by a team of seasoned electrophysiology innovators from both the United States and China, EnChannel is developing a holistic platform that unifies magnetic-impedance navigation, intracardiac echocardiography, full-chamber 5D action-potential mapping, and mid-voltage (<1000 V) pulsed-field ablation to deliver safe and personalized treatment for patients with atrial fibrillation. EnChannel is well positioned to expand its global innovation and advance its mission to transform AF care through data-driven, patient-specific therapy solutions. For more information, visit and follow us on LinkedIn. EnChannel's mapping and ablation products are investigational devices and are limited by federal (or United States) law to investigational use. Media Contact Bradley Wegrzynowicz (610) 462-0197 [email protected] SOURCE EnChannel Medical Ltd.
Globe and Mail
an hour ago
- Globe and Mail
Digi Power X Reports 45% Month-Over-Month Increase in Cash and Crypto Position with no Long-Term Debt and Reports June 2025 Production Results
This news release constitutes a 'designated news release' for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025 MIAMI, July 01, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (' Digi Power X ' or the ' Company ') (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops data centers, is pleased to provide unaudited comparative Bitcoin (' BTC ') production results for the quarter and month ended June 30, 2025, combined with an operations update. All monetary references are expressed in U.S. dollars unless otherwise indicated. Second Quarter 2025 Production Highlights The value of coins produced at the Company's facilities between its self-mining and colocation agreements and energy sales was approximately $12.4 million in Q2 2025 (based on a BTC price of $107,750 as of June 30, 2025, per CoinMarketCap). Miners running at the Company's facilities produced approximately 94 BTC during the quarter between self-mining and colocation agreements, representing an approximate value of $10.1 million (based on a BTC price of $107,750 as of June 30, 2025, per CoinMarketCap). The Company earned gross energy and power revenue of approximately $2.3 million for the three-month period ended June 30, 2025 through the provision of power capacity to market customers. Monthly Production Highlights for June 2025 The Company held cash, BTC and cash deposits of approximately $13.5 million as of June 30, 2025, as compared to $9.3 million on May 31, 2025 (based on a BTC price of $107,750 as of June 30, 2025, and $105,800 as of May 31, 2025, per CoinMarketCap), representing an increase of 45% over the previous month. On a year-over-year basis, the Company's total cash and crypto position increased by approximately 90% as compared to June 30, 2024. The Company has invested approximately $3.5 million year-to-date in capital expenditures and mining infrastructure support equipment, including approximately $1.0 million in June. Strategic Partnership with Super Micro One of the Company's most meaningful developments this past quarter was the launch of its partnership with Super Micro Computer, Inc. (Nasdaq: SMCI) (' Super Micro '), a global leader in high-performance, energy-efficient server technology. Together with Super Micro, the Company is building artificial intelligence (' AI ') data center systems powered by NVIDIA's B200 GPUs, to be implemented at the Company's Alabama data center facility. Digi Power X's first deployment is expected to be a high-performance AI compute cluster built with Super Micro's liquid-cooled server infrastructure. This cluster will power the launch of the Company's ARMS™ (AI-Ready Modular Solution) platform, a Tier 3-certified modular data center designed specifically for dense AI and HPC workloads. The ARMS 200, the Company's flagship modular unit, is in final preparation for installation at the Company's Tier 3 data center in Alabama. The planned deployment will serve as a live demonstration of the Company's ability to deliver full-stack compute infrastructure quickly and reliably. As AI infrastructure enters a new phase of growth, driven by massive demand for training, inference and enterprise deployment, Digi Power X plans to use its vertically integrated approach to position itself as a preferred provider for modular, energy-backed AI infrastructure. NANO Nuclear Energy Inc. The Company, in collaboration with NANO Nuclear Energy Inc. (NASDAQ: NNE) (' NANO Nuclear '), a leading advanced nuclear energy and technology company focused on developing portable, clean energy solutions, continues to monitor the joint submission made in December 2024 to a New York State Energy Research and Development Authority Request for Information concerning the development of advanced nuclear energy technologies in New York State. This joint submission builds on the Memorandum of Understanding between NANO Nuclear and Digi Power X that was announced on December 13, 2024, to advance the transition to carbon-free energy at Digi Power X's 60MW power plant in upstate New York, and allow the parties to participate in New York State's pursuit of strategic partnerships and initiatives that align with its goals of achieving a zero-emission grid in its future for all New Yorkers. Operations Update The Company currently operates with approximately 100MW of available power across its three sites and is working to expand its capacity to 200MW and beyond. The Company plans to fuel this growth using its existing asset portfolio, combined with strategic expansion through targeted acquisitions. About Digi Power X Digi Power X is an innovative energy infrastructure company that develops data centers to drive the expansion of sustainable energy assets. For further information, please contact: Michel Amar, Chief Executive Officer Digi Power X Inc. Investor Relations T: 888-474-9222 Email: IR@ Cautionary Statement Trading in the securities of the Company should be considered highly speculative. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements Except for the statements of historical fact, this news release contains 'forward-looking information' and 'forward-looking statements' (collectively, 'forward-looking information') that are based on expectations, estimates and projections as at the date of this news release and are covered by safe harbors under Canadian and United States securities laws. Forward-looking information in this news release includes information about potential further improvements to profitability and efficiency across the Company's operations, including, as a result of the Company's expansion efforts, potential for the Company's long-term growth and clean energy strategy, and the business goals and objectives of the Company. Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to: future capital needs and uncertainty of additional financing; share dilution resulting from equity issuances; risks relating to the strategy of maintaining and increasing Bitcoin holdings and the impact of depreciating Bitcoin prices on working capital; effects on Bitcoin prices as a result of the most recent Bitcoin halving; development of additional facilities and installation of infrastructure to expand operations may not be completed on the timelines anticipated by the Company, or at all; ability to access additional power from the local power grid and realize the potential of the clean energy strategy on terms which are economic or at all; a decrease in cryptocurrency pricing, volume of transaction activity or generally, the profitability of cryptocurrency mining; further improvements to profitability and efficiency may not be realized; development of additional facilities to expand operations may not be completed on the timelines anticipated by the Company; ability to access additional power from the local power grid; an increase in natural gas prices may negatively affect the profitability of the Company's power plant; the digital currency market; the Company's ability to successfully mine digital currency on the cloud; the Company may not be able to profitably liquidate its current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on the Company's operations; the volatility of digital currency prices; and other related risks as more fully set out in the Annual Information Form of the Company and other documents disclosed under the Company's filings at and The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about, among other things, the current profitability in mining cryptocurrency (including pricing and volume of current transaction activity); profitable use of the Company's assets going forward; the Company's ability to profitably liquidate its digital currency inventory as required; historical prices of digital currencies and the ability of the Company to mine digital currencies on the cloud will be consistent with historical prices; the ability to maintain reliable and economical sources of power to run its cryptocurrency mining assets; the negative impact of regulatory changes in the energy regimes in the jurisdictions in which the Company operates; and there will be no regulation or law that will prevent the Company from operating its business. The Company has also assumed that no significant events occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainties therein. The Company undertakes no obligation to revise or update any forward-looking information other than as required by applicable law.
